Medical Industry

This is a book of miracles - medical events witnessed by leading physicians for which there is no reasonable medical explanation, or, if there is, the explanation itself is extraordinary. These dramatic first-person essays detail spectacular serendipities, impossible cures, breathtaking resuscitations, extraordinary awakenings, and recovery from unimaginable disasters. Miracles We Have Seen is a book of inspiration and optimism, and a compelling glimpse into the lives of physicians.

It’s the business of saving lives. Miracle Medicines goes behind the scenes of the pharmaceutical industry and into the high-security laboratories to tell the stories of the men and women - chemists, physiologists, medical and clinical researchers, engineers - who have chosen to toil for years in the lab in order to transform scientific theories into new lifesaving medicines. You’ll witness the day-to-day labors, victories and defeats of the dedicated professionals who are waging a war against the diseases that still plague mankind.

There is perhaps no more important value than fundamental human equality. And yet, despite large percentages of people affirming the value, the resources available to explain and defend the basis for such equality are few and far between. In his newest book, Charles Camosy provides a thoughtful defense of human dignity.

For years after graduating from medical school, Dr. Clifton K. Meador assumed that symptoms of the body, when obviously not imaginary, indicate a disease of the body - something to be treated with drugs, surgery, or other traditional means. But, over several decades, as he saw patients with clear symptoms but no discernible disease, he concluded that his own assumptions were too narrow and, indeed, that the underlying basis for much of clinical medicine was severely limited.

The timeless human desire to be more beautiful, intelligent, healthy, athletic, or young has given rise in our time to technologies of human enhancement. Some condemn these developments as a new kind of cheating - not just in sports but in life itself - promising rewards without effort and depriving us most of all of what it means to be authentic human beings. "Transhumanists", on the other hand, reject what they see as a rationalizing of human limits, as if being human means being content forever with underachieving bodies and brains.

In Good Blood, best-selling writer Julian Guthrie tells the gripping tale of the race to cure a horrible affliction known as Rh disease that stalked families and caused a mother’s immune system to attack her own unborn child. The story is anchored by two very different men on two continents: Dr. John Gorman in New York, who would land on a brilliant yet contrarian idea, and the unassuming Australian whose almost magical blood - and his unyielding devotion to donating it - would save millions of lives.

In the new essays collected here, an interdisciplinary group of scholars asks age-old questions about the nature and well-being of humans in the context of a revolutionary new biotechnology - one that has the potential to change the genetic make-up of both existing people and future generations. Welcoming listeners who study related issues and those not yet familiar with the formal study of bioethics, the authors of these essays open up a conversation about the ethics of gene editing.

Against a global backdrop of wartime suffering and postwar hope, Borrowing Life gathers the personal histories of the men and women behind the team that enabled and performed the modern medical miracle of the world's first successful organ transplant.

Dr. Aaron Berkowitz had just finished his neurology training when he was sent to Haiti on his first assignment with Partners in Health. There, he meets Janel, a 23-year-old man with the largest brain tumor Berkowitz or any of his neurosurgeon colleagues at Harvard Medical School have ever seen. Determined to live up to Partners in Health’s mission statement “to bring the benefits of modern medical science to those most in need”, Berkowitz tries to save Janel’s life by bringing him back to Boston for a 12-hour surgery.

Dr. Lange graduated from medical school in 1981, right as a new plague swept across the globe. His story became intertwined with the story of HIV. At once a physician, scientist, AIDS activist, and medical diplomat, Lange studied ways to battle HIV and prevent its spread from mother to child. Fighting the injustices of poverty, Lange advocated for better access to health care for the poor and the vulnerable. The Impatient Dr. Lange is the story of one man's struggle against a global pandemic - and the tragic attack that may have slowed down the search for a cure.

Every doctor is haunted by memories of difficult patients. People whom, despite all of their patience and persistence and the best communication, diagnostic and reasoning skills, they haven't helped. And anyone who has been a patient will tell you about encounters with difficult doctors, of relationships freighted with mutual bafflement, hostility and pain. Despite its vast resources, medicine is so often destined to fail people. Written by a practising GP, this book is told through stories of Dr Peter Dorward's hardest cases.

Biosecurity Dilemmas examines conflicting values and interests in the practice of "biosecurity," the safeguarding of populations against infectious diseases through security policies. Biosecurity encompasses both the natural occurrence of deadly disease outbreaks and the use of biological weapons. Christian Enemark focuses on six dreaded diseases that governments and international organizations give high priority for research, regulation, surveillance, and rapid response: pandemic influenza, drug-resistant tuberculosis, smallpox, Ebola, plague, and anthrax. The book is organized around four ethical dilemmas that arise when fear causes these diseases to be framed in terms of national or international security: protect or proliferate, secure or stifle, remedy or overkill, and attention or neglect.

Sarah Thebarge, a Yale-trained physician assistant, nearly died of breast cancer at age 27, but that did not end her deeply felt spiritual calling to medical missions in Africa. Risking her own health, she moved to Togo, West Africa - ranked by the United Nations as the least happy country in the world - to care for sick and suffering patients. Serving without pay in a mission hospital, she pondered the intersection of faith and medicine in her quest to help make the world "well".

David M. Craig traveled across the US to assess its health care access, delivery, and finance. He interviewed religious hospital administrators and interfaith activists, learning how they balance the values of economic efficiency and community accountability. He discovered that health care in the US is not a private good or a public good, but a shared social good. This book argues that as escalating health costs absorb more and more of family income and government budgets, we need to take stock of the full range of health care values.

In November 1942, Paul Andrew Kennedy (1912-1993) boarded the St. Elena in New York Harbor and sailed for Casablanca as part of Operation Torch, the massive Allied invasion of North Africa. As a member of the US Army's 2nd Auxiliary Surgical Group, he spent the next 34 months working in North Africa, Italy, France, and Germany, in close proximity to the front lines and often under air or artillery bombardment. He was uncomfortable, struck by the sorrows of war, and homesick for his wife.

What is embryonic stem cell research? Why is it so controversial? What is its relationship to human cloning? Events are moving so fast and biotechnology seems so complicated that many of us don't have an informed opinion about issues that are remaking the human future before our very eyes.

In Mercies in Disguise, acclaimed New York Times reporter and best-selling author Gina Kolata tells the story of the Baxleys, an upstanding family in small-town South Carolina. Many of them were doctors, but still, they are struck down by an inscrutable illness. Finally they discover the cause of the disease after a remarkable sequence of providential events. Meanwhile science, progressing for 50 years along a parallel track, handed the Baxleys a question - not a cure but a blood test that would reveal who had the gene for the disease.

Already technology enables parents to select some genetic traits for their children, and soon it will be possible to begin to shape ourselves as a species. Countering loud cries of alarm, bioethics expert Ronald Green explains why our fears about genetic engineering are overblown and how we can move forward responsibly to create a better future.

Moneyball meets medicine in this remarkable chronicle of one of the greatest scientific quests of our time - the groundbreaking program to answer the most essential question for humanity: How do we live and die? - and the visionary mastermind behind it.

Each year thousands of people die waiting for organ transplants. Many of these deaths could have been prevented were it not for the almost universal moral hand-wringing over the concept of selling human organs. Author and bioethicist Mark Cherry reasserts the case that health care could be improved and lives saved by introducing a regulated transplant organs market rather than by well-meant, but misguided, prohibitions.